Yi Zhang
Fujian Medical University(CN)National Institutes of Health(US)Shanghai Medical College of Fudan University(CN)Zunyi Medical University(CN)Capital Medical University(CN)Sichuan University(CN)Fudan University(CN)West China Medical Center of Sichuan University(CN)ShanghaiTech University(CN)Xian Center for Disease Control and Prevention(CN)West China Second University Hospital of Sichuan University(CN)West China Hospital of Sichuan University(CN)Jiaxing University(CN)Xi'an Honghui Hospital(CN)Fujian Entry - Exit Inspection and Quarantine Bureau(CN)AstraZeneca (Netherlands)(NL)Jiangsu Provincial Center for Disease Control and Prevention(CN)National Institute of Health of Thailand(TH)Second Affiliated Hospital of Xi'an Jiaotong University(CN)National Institute of Allergy and Infectious Diseases(US)AstraZeneca (Poland)(PL)Puer University(CN)Beijing Ditan Hospital(CN)AstraZeneca (United States)(US)Guangdong Provincial Center for Disease Control and Prevention(CN)Huashan Hospital(CN)Institute of Infection and Immunity(CA)Xi'an Jiaotong University(CN)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Animal Virus Infections Studies, SARS-CoV-2 detection and testing, Viral gastroenteritis research and epidemiology
Most-Cited Works
- → SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness(2020)1,618 cited
- → Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates(2020)1,152 cited
- → Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection(2015)713 cited
- → The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates(2021)489 cited
- → LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants(2022)455 cited
- → Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost(2021)375 cited